Evidence map›Paper›PMID 42060566›Full record

ArticleInternational archives of allergy and immunology2026

The Prevalence of Alpha-Gal IgE among Patients with Confirmed Lyme Serology Result.

Kamran Kadkhoda, Alison Schwaben, Matthew Dee

Abstract read
In one paragraph

Article in International archives of allergy and immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kamran KadkhodaImmunopathology Laboratory, Robert J. Tomsich Pathology and Laboratory Medicine Department, Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio, USA, kadkhok@ccf.org.
Alison SchwabenImmunopathology Laboratory, Robert J. Tomsich Pathology and Laboratory Medicine Department, Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Matthew DeeImmunopathology Laboratory, Robert J. Tomsich Pathology and Laboratory Medicine Department, Diagnostics Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGiven the significant rise in the incidence of alpha-gal syndrome alongside the geographical expansion of ticks in recent years, it is crucial to conduct studies aimed at raising awareness particularly among patients with a history of, or current diagnosis of, Lyme disease, to improve their quality of life. Our study is unique in addressing this important intersection.

methodsTwo groups composed of 200 residuals de-identified samples originally collected during the peak of tick activity season in Northeast Ohio were tested for alpha-gal IgE. The first group (n = 100) was from patients with Lyme IgG Western blot positive results, and the remainder were from healthy subjects only tested for immune status.

resultsOf the 200 samples, 17 tested positive for α-Gal IgE: 15 from the Lyme-positive group and 2 from the control group. A Fisher's exact test showed strong statistical significance between the two groups (p = 0.0015).

conclusionAlthough alpha-gal syndrome had been previously associated with a history of American lone start tick bite, this study for the first time in North America shows a possible association between α-Gal IgE positivity and exposure to Ixodes ticks. This is of paramount importance given the vast prevalence of Ixodes ticks especially in areas where the American lone start ticks are scarce.

Indexed as

Alpha-galIxodesLymeTick

Identifiers

PMID42060566
PMCPMC13275050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.